S.O.D. Support

by AN American Nutriceuticals · tablet or pill · 190 tablets

  • On the market (NIH)
  • UPC 8 59658 00000 5
  • DSLD label 336681
  • Serving 5 capsules
  • 38 servings

S.O.D. Support by AN American Nutriceuticals lists one ingredient: 400 mg of organic fetal wheat sprout concentrate per serving of 5 capsules. Its current label entered the NIH Dietary Supplement Label Database on August 22, 2025.

What is in S.O.D. Support?

Each row as the label prints it, per serving of 5 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

S.O.D. Support: Supplement Facts rows against the market (DSLD label 336681, January 2026 release)
IngredientAmount% DVAmong products listing it
organic fetal Wheat sprout concentrate400 mgWheat in S.O.D. Support against 142 products400 mg per serving; the middle half of products list 70 mg to 983 mg, the median 320 mg.400 mg

Higher than 60% of 142 products listing wheat (median 320 mg). Per day at the most servings: 800 mg.

Source: NIH ODS Dietary Supplement Label Database, label 336681 (entered August 22, 2025), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use: Take 5 tablets twice per day or as directed by your health care professional. Recommended to be taken at least 30 minutes away from meals.
Allergens and what it does not contain
No BPA
Contains no yeast, gluten, sugar, starch, dairy or soy.

Source: label statements in DSLD label 336681.

What else is on the label?

Other ingredients: Cellulose.

How many labels does S.O.D. Support have?

5 labels are on file under this name since August 26, 2014: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 336681 (current) Entered August 22, 2025 · on the market · 190 tablets · UPC 8 59658 00000 5
  2. Label 315863 Entered October 24, 2024 · on the market · 190 tablets · UPC 8 59658 00000 5
  3. Label 187390 Entered February 25, 2019 · off the market January 29, 2024 · 190 tablets
  4. Label 47874 Entered July 24, 2015 · off the market July 10, 2018 · 190 tablets
  5. Label 36550 Entered August 26, 2014 · off the market July 16, 2015 · 190 tablets · UPC 8 59658 00000 0

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names AN American Nutriceuticals (distributor), Flagler Beach, FL. All AN American Nutriceuticals products.

Where next?